Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAR-0100A for Working Memory in Schizotypal Personality Disorder
NCT02507206Phase 2Completed
- Start
- Apr 2013
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dihydrexidine in schizotypal personality disorder (STPD). Started Apr 2013; status: completed.
02
Drugs
dihydrexidine
03
Conditions
schizotypal personality disorder (STPD)
Beyond the preview
Go deeper on NCT02507206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02507206.